Different sensitivity of CD19-positive bone marrow and lymph node lymphoblasts may cause resistance to blinatumomab in relapsed B-cell acute lymphoblastic leukemia/lymphoma - Aix-Marseille Université Accéder directement au contenu
Article Dans Une Revue Leukemia & lymphoma Année : 2020

Different sensitivity of CD19-positive bone marrow and lymph node lymphoblasts may cause resistance to blinatumomab in relapsed B-cell acute lymphoblastic leukemia/lymphoma

Fichier non déposé

Dates et versions

hal-03159741 , version 1 (04-03-2021)

Identifiants

Citer

Vadim Ivanov, Laure Farnault, Cedric Mercier, Cecile Colavolpe, Geoffroy Venton, et al.. Different sensitivity of CD19-positive bone marrow and lymph node lymphoblasts may cause resistance to blinatumomab in relapsed B-cell acute lymphoblastic leukemia/lymphoma. Leukemia & lymphoma, 2020, 61 (5), pp.1230-1233. ⟨10.1080/10428194.2019.1706737⟩. ⟨hal-03159741⟩

Collections

CNRS UNIV-AMU
17 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More